Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.

Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL Jr, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG.

Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641. Review. No abstract available.

3.

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison JJ, Suarez Almazor M, Bridges SL Jr, Chatham WW, Hochberg M, MacLean C, Mikuls T, Moreland LW, O'Dell J, Turkiewicz AM, Furst DE; American College of Rheumatology..

Arthritis Rheum. 2008 Jun 15;59(6):762-84. doi: 10.1002/art.23721. No abstract available.

4.

Updated recommendations for the treatment of rheumatoid arthritis: another step on a long road.

Daikh DI, St Clair EW.

Arthritis Care Res (Hoboken). 2012 May;64(5):648-51. doi: 10.1002/acr.21659. No abstract available.

5.
6.
7.
8.

Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy.

Caporali R, Conti F, Alivernini S, Atzeni F, Seriolo B, Cutolo M, Valesini G, Ferraccioli G, Sarzi-Puttini P, Salvarani C, Guiducci S, Zampogna G, Gremese E, Pipitone N, Scrivo R, Bugatti S, Montecucco C, Matucci-Cerinic M; Italian Society for Rheumatology..

Clin Exp Rheumatol. 2011 May-Jun;29(3 Suppl 66):S7-14. Epub 2011 Jul 26. Review.

PMID:
21906423
9.

Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety.

Favalli EG, Caporali R, Sinigaglia L, Pipitone N, Miniati I, Montecucco C, Matucci-Cerinic M; Italian Society for Rheumatology..

Clin Exp Rheumatol. 2011 May-Jun;29(3 Suppl 66):S15-27. Epub 2011 Aug 29. Review.

PMID:
21906424
10.

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis.

Nam JL, Ramiro S, Gaujoux-Viala C, Takase K, Leon-Garcia M, Emery P, Gossec L, Landewe R, Smolen JS, Buch MH.

Ann Rheum Dis. 2014 Mar;73(3):516-28. doi: 10.1136/annrheumdis-2013-204577. Epub 2014 Jan 7. Review. Erratum in: Ann Rheum Dis. 2015 Jan;74(1):320.

PMID:
24399231
11.

American College of Rheumatology treatment guidelines continue to omit guidance on glucocorticoids: comment on the article by Singh et al.

Boers M, Kirwan JR, Bijlsma JW.

Arthritis Care Res (Hoboken). 2012 Oct;64(10):1622. doi: 10.1002/acr.21770. No abstract available.

12.

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, Curtis JR, Furst DE, Parks D, Kavanaugh A, O'Dell J, King C, Leong A, Matteson EL, Schousboe JT, Drevlow B, Ginsberg S, Grober J, St Clair EW, Tindall E, Miller AS, McAlindon T.

Arthritis Rheumatol. 2016 Jan;68(1):1-26. doi: 10.1002/art.39480. Epub 2015 Nov 6. Review.

13.

British Society for Rheumatology Biologics Register.

Silman A, Symmons D, Scott DG, Griffiths I.

Ann Rheum Dis. 2003 Nov;62 Suppl 2:ii28-9.

14.

[The proposal of the Croatian Society for Rheumatology for the treatment of adult rheumatoid arthritis patients with biologics, 2013].

Babić-Naglić D, Anić B, Čikeš N, Novak S, Grazio S, Morović-Vergles J, Kehler T, Marasović-Krstulović D, Milanović S, Hanih M, Perić P, Vlak T, Potokič K, Ćurković B; Croatian Society for Rheumatology (HRD) of Croatian Medical Association (HLZ)..

Reumatizam. 2013;60(1):47-51. Croatian.

PMID:
24003685
15.

Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.

Harrold LR, Reed GW, Kremer JM, Curtis JR, Solomon DH, Hochberg MC, Kavanaugh A, Saunders KC, Shan Y, Spruill TM, Pappas DA, Greenberg JD.

Arthritis Res Ther. 2016 Apr 26;18:94. doi: 10.1186/s13075-016-0992-3.

16.

[Rheumatoid arthritis: milestones in classification and treatment].

Fiehn C.

Dtsch Med Wochenschr. 2011 Feb;136(5):203-5. doi: 10.1055/s-0031-1272510. Epub 2011 Jan 26. Review. German.

PMID:
21271482
17.

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, Curtis JR, Furst DE, Parks D, Kavanaugh A, O'Dell J, King C, Leong A, Matteson EL, Schousboe JT, Drevlow B, Ginsberg S, Grober J, St Clair EW, Tindall E, Miller AS, McAlindon T; American College of Rheumatology..

Arthritis Care Res (Hoboken). 2016 Jan;68(1):1-25. doi: 10.1002/acr.22783. Epub 2015 Nov 6. Review.

18.

American College of Rheumatology recommendations for the treatment of RA: an issue of choices.

Landewé RB.

Nat Clin Pract Rheumatol. 2009 Jan;5(1):8-9. doi: 10.1038/ncprheum0958. Epub 2008 Nov 25. No abstract available.

PMID:
19030006
19.

Assessment and management of rheumatoid arthritis.

Haraoui B.

J Rheumatol Suppl. 2009 Jun;82:2-10. doi: 10.3899/jrheum.090124. Review. Erratum in: J Rheumatol. 2009 Aug;36(8):1851.

PMID:
19509324
20.

Adherence to biologic DMARD therapies in rheumatoid arthritis.

Koncz T, Pentek M, Brodszky V, Ersek K, Orlewska E, Gulacsi L.

Expert Opin Biol Ther. 2010 Sep;10(9):1367-78. doi: 10.1517/14712598.2010.510508. Review.

PMID:
20681888

Supplemental Content

Support Center